{"adverse_reactions":["6 ADVERSE REACTIONS"],"clinical_pharmacology":["12 CLINICAL PHARMACOLOGY"],"clinical_studies":["14 CLINICAL STUDIES"],"contraindications":["4 CONTRAINDICATIONS"],"description":["11 DESCRIPTION"],"dosage_and_administration":["2 DOSAGE AND ADMINISTRATION"],"dosage_forms_and_strengths":["3 DOSAGE FORMS AND STRENGTHS"],"drug_abuse_and_dependence":["9 DRUG ABUSE AND DEPENDENCE"],"drug_interactions":["7 DRUG INTERACTIONS"],"effective_time":"20160331","id":"2f5e3466-1711-1532-e054-00144ff8d46c","indications_and_usage":["1 INDICATIONS AND USAGE"],"information_for_patients":["17 PATIENT COUNSELING INFORMATION"],"nonclinical_toxicology":["13 NONCLINICAL TOXICOLOGY"],"openfda":{},"overdosage":["10 OVERDOSAGE"],"package_label_principal_display_panel":["18 PACKAGE LABEL.PRINCIPAL DISPLAY PANEL GABAPENTIN 300mg90CAPS"],"set_id":"2f5e3466-1710-1532-e054-00144ff8d46c","spl_product_data_elements":["GABAPENTIN GABAPENTIN FERRIC OXIDE YELLOW GABAPENTIN GABAPENTIN FERROSOFERRIC OXIDE STARCH, CORN D&C YELLOW NO. 10 FD&C BLUE NO. 1 SODIUM LAURYL SULFATE FD&C RED NO. 40 FD&C BLUE NO. 2 GELATIN MANNITOL PROPYLENE GLYCOL FERRIC OXIDE RED SILICON DIOXIDE TALC TITANIUM DIOXIDE SHELLAC 2666"],"storage_and_handling":["15 STORAGE AND HANDLING"],"use_in_specific_populations":["8 USE IN SPECIFIC POPULATIONS"],"version":"1","warnings_and_cautions":["​5 WARNINGS AND PRECAUTIONS"]}